Riktkurs.nu
EN | SV
VNV GlobalMid Cap
Stockholm Stock Exchange | Mid Cap
Xvivo Perfusion
+60.26%
Latest
+56.69%
3 months
HandelsbankenDNB CarnegiePareto SecuritiesSEB EquitiesSEBDanske BankDNBDanske Bank MarketsDNB MarketsCarnegieBryan Garnier

Price Targets For Xvivo Perfusion

AnalystPrice TargetDateUpside
Handelsbanken300 SEKOct 20
+60.26%
DNB Carnegie300 SEKOct 6
Pareto Securities280 SEKOct 2
SEB Equities610 SEKOct -24
SEB600 SEKJul -24
Danske Bank560 SEKJul -24
DNB468 SEKApr -24
Danske Bank Markets405 SEKApr -24
DNB Markets418 SEKJan -24
Carnegie350 SEKJan -24
Bryan Garnier340 SEKNov -23

About The Company

XVIVO is a medical technology company firmly rooted within medical science with more than 20 years of experience in the transplantation area.
Xvivo Perfusion

The information on Riktkurs.nu is for general information purposes only. Riktkurs.nu makes no guarantees of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to Riktkurs.nu or the information, products, services, or related information on Riktkurs.nu for any purpose. The recipient is recommended to complete his or her decision basis with the material deemed necessary. We reserve us for all types of errors as well as any malfunctions of the website. The information on Riktkurs.nu should not be seen as a recommendation to buy or sell a security.
© Riktkurs.nu 2025
Updated 10/30/2025 10:02:24 AM